Biotech Names Flexing Their Muscles

 | Oct 04, 2017 | 11:06 AM EDT
  • Comment
  • Print Print
  • Print
Stock quotes in this article:










For about three weeks now we have had a similar pattern of little movement at the open. With the exception of just two days during that period buy programs have triggered in the final hour and closed the indices near the highs. The Nasdaq 100 ETF (QQQ) has been a bit of an exception, but for the overall pattern of action is amazingly consistent.

This morning we have another slow start but breadth is running a little negative with about 3,000 gainers to 3,200 decliners. New highs are still plentiful but the pockets of momentum are harder to find. It is a market for stock pickers but it is more difficult because the themes are muddled.

I'm seeing some good strength in biotechnology names again. Global Blood Therapeutics (GBT) , for example, is active due to a filing showing that Stevie Cohn has a big position.

My Stock of the Week, Antares Pharma (ATRS) , is a small biotechnology name and is trading up 5% so far. While the overall market has a surprising low level of volatility the stock-picking remains quite good. That is largely a function of outperformance by small-caps but that is the place to be.

(Antares Pharma is a holding in TheStreet's Stocks Under $10 portfolio. Click here to learn more about this product.)

If you are looking for a negative spin to the action you can argue that when the market expends a high level of energy and only manages small gains it is a sign that momentum is slowing and a reversal is approaching.

That is a very logical argument but so far we are not seeing any proof that it works. I'm staying focused on stock-picking and have some names such as AVEO Pharmaceuticals (AVEO) and GDS Holdings (GDS) on my radar.

The QQQ is lagging again while small-caps are leading. That supports a focus on stock-picking. When the small-caps start to lag that will be the time to focus more on defense.

Columnist Conversations

Will someone finally just buy this company for $55 to $60 a share and call it a day? Board ended talks with th...
View Chart »  View in New Window » AIG WEEKLY AIG 15 minute trigger chart
In theory everyone hates the idea of invasion of privacy by social media, but in reality most people make an e...
In answer to Brian's question, I don't think Sunday night's Uber fatal self-driving car accident pos...



News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.